Genentech Breaks Ground on $750 Million Hillsboro Facility Expansion

Biopharmaceutical company Genentech has broken ground on a $750 million expansion at its Hillsboro campus. The project will add device-filling capabilities to the facility, supporting domestic production and supply chain capacity for therapies used in oncology, immunology, and neurology.

The expansion is projected to generate roughly 450 jobs across construction and manufacturing operations. The Hillsboro campus has operated as a manufacturing site for Genentech for nearly twenty years. State and local officials highlighted the development as a key step in expanding Oregon's life sciences and advanced manufacturing sectors.